Simultaneously detects HCV core antigen and anti-HCV antibodies for more accurate screening Reduces window period to less than 28 days, resulting in earlier diagnosis Next-gen testing solution suitable for blood banks Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company, committed to a Healthier India,
POST TAGS:
4th gen ELISA kitand Chair - Infection ControlChennaiCOVID-19diagnostic equipmentDr. Anusha RohitErbaLisa HCV Gen 4 Ag+Ab kitErbaLisa HCV Gen4 Ag+AbHCV ElisaHealthier IndiaHepatitisinflammationjaundiceMadras Medical MissionNational Institute of Biologicals (NIB)pathology laboratoriespathology labsquotedSr. Consultant & Head of Department - Microbiologytest kitsTransasia Bio-Medicals Ltd.Transfusion Transmitted Infections (TTIs)
